Institutional investors hold a majority ownership of PCRX through the 109.57% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended June 2017, these large investors purchased a net $1.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POINT72 ASSET MANAGEMENT LP Bought 1.3 Million shares of Pacira Pharmaceuticals In...